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 Various Insilico based genome screening methods helped us in identifying the 
key drug targets for  a pathogen. The accuracy of the predictions are 
systematically based on the benchmarks at different stages of methodology and 
the kind of dataset which is considered for the study. In the current study, we 
made an effort to screen the entire proteome of Bacillus anthracis for 
identification of putative drug targets. B. anthracis is the causautive agent for 
anthrax disease. Instead of genome sequence, the metabolically classified 
proteome of B. anthracis from JCVI-CMR database was considered for the 
present study. The entire proteome is been categorized into 25 different 
metabolisms and in each sub-categorised metabolisms respective protein 
sequences were retrieved and subjected to screening against Database of 
Essential Genes (DEG) and Human-Basic Local Alignment Search Tool (H-
BLAST) databases. In total 136 essential genes/proteins were obtained from the 
DEGp (protein) screening whereas 145 Non-Human Homologs (NHHs) were 
predicted. The identified 145 NHHs are further subjected to criteria based 
selection to identify the most suitable, functional, putative drug targets. The 8 
common hits of both DEG and H-BLAST were considered to be better 
potential targets as they justify the criteria of being an essential gene/protein, 
non-human homolog, availability of the 3D structure in PDB and having a 
significant functional role in the cellular biochemical processes.   
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1. INTRODUCTION 
The genome sequencing projects of various pathogens is becoming increased day-by-day, resulting the 
genomic data to be analyzed by diverse approaches to identify the putative anti-pathogenic drug targets and 
vaccine candidates. Insilico methods can be used to identify putative gene products through the comparative 
genomics approach [1]. One of the approach in comparative genomics is applying the subtractive genomics by 
which it enables the subtraction of datasets between the host and pathogen genome and provides information for 
a set of genes that are likely to be essential to the pathogen but absent in the host [2], that is human and should 
have no homolog in human, so that when a drug or a lead compound is designed considering the potential target 
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it should only be against the mechanism and functionality of the pathogen not the host. The current studies make 
use of the subtractive proteomics approach to analyze the complete proteome of Bacillus anthracis to search for 
potential drug targets [3].  
Bacillus anthracis, the organism that causes anthrax is a large Gram positive, aerobic, spore bearing 
bacillus, 1–1.5 X 3–10 µm in size, is the only obligate pathogen within the genus bacillus [4].  The disease 
occurs mostly in wild or domestic mammals and may occur in humans when exposed to infected animals, or 
upon direct exposure. Fully virulent forms of B. anthracis carry two large plasmids: pXO1 and pXO2 [5]. 
Plasmid pXOl encodes for three toxins: lethal factor, edema factor (calmodulin-dependent adenylate cyclase), 
and the protective antigen. These proteins are individually nontoxic; however, they act in binary combinations 
and produce two distinct toxic responses in the host organism: edema and cell death [6], whereas the pXO2 
plasmid encodes the capsule which is composed of a high-molecular-weight polypeptide (poly-D-glutamic acid) 
which inhibits host phagocytosis of the vegetative form of B. anthracis.  
B. anthracis is considered to be one of the most likely biological warfare agents due to the ability of its 
spores to be transmitted by the respiratory route, the high mortality associated with inhalation anthrax, and spore 
stability [5]. Its use as a potential bioweapon has accelerated the race to develop vaccines and antitoxins for this 
Category A bioterrorism agent as defined by the National Institute of Allergy and Infectious Diseases (NIAID). 
Currently drugs such as ciprofloxacin, doxycycline and Penicillin-G are used for the therapy and licensed 
anthrax vaccine named Anthrax Vaccine Adsorbed (or AVA) is recommended. As this is only single anthrax 
vaccine licensed in U.S., the new vaccines are in the underdevelopment stage. As well the drug therapies are 
commonly done on post-exposure prophylaxis. Requirement of booster doses frequently for vaccine and pro-
longed therapies with antibiotics, thus underscores the need of new drug target(s) for development of effective 
drug against the B. anthracis. 
 
2. RESEARCH METHOD 
 
2.1. Strain Selection and Retrieval of Metabolic Profile based Proteome 
As many B. anthracis strains genomes are available in the genome databases such as National Center 
for Biotechnology Information (NCBI) Genomes, J. Craig Venter Institute-Comprehensive Microbial Resource 
(JCVI-CMR) [7], and PAThosystems Resource Integration Center (PATRIC) [8], the strain selection was done 
by the comparative analysis of specific attributes like: Review information (Recently updated), Number of 
protein-coding genes (5902), Status of sequencing (Completed), Plasmid coding (two plasmids coding virulence 
factors). Taking into account these attributes, a Bacillus anthracis strain CDC 684 (Accession Number: 
NC_012581.1) was selected for the current study.  
The total number of protein-coding genes including the genome and both the plasmids in B. anthracis 
CDC 684 strain are 5902 according to the Comprehensive Microbial Resource (CMR) database.  
(http://cmr.jcvi.org/cgi-bin/CMR/CmrHomePage.cgi) which has the same numbers of genes data represented 
into respective functional metabolisms with the Gene locus information for each of the protein-coding gene. The 
protein coding genes were retrieved from the tool - Role Category Pie Chart in JCVI-CMR database, which 
shows the number and percentage of genes/proteins for every metabolic role category in the CMR (Fig. 1).  
The number of genes involved in each metabolism gives an overview of the active metabolism 
functioning in an organism. As Swiss-prot database is consisting of highly annotated protein sequences, the 
protein sequences(s) for each gene of respective metabolism were retrieved by using the gene locus information 
as query. The retrieved sequences were further used/implied to find the probable drug targets. 
Currently, the JCVI-CMR database is no longer supported and been taken offline. But all the metabolic 
based proteome data can be retrieved back reliably by using Gene locus IDs from Uniprot protein sequence 
database.  
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Figure 1a. Metabolic Role Category Pie chart 
 
 
Figure 1b. Number of Protein-Coding Genes involved in Various Metabolic Categories 
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2.2. Finding the Essentiality of Proteins  
Database of Essential Genes (DEG) provides the information about the essential genes which are 
indispensible for the survival of an organism [9]. Protein sequences those retrieved from Swiss-Prot in FASTA 
format are subjected to Prokaryotic DEG-BLAST by selecting the blastp (Protein Query vs. Protein DB) 
program. The essential genes are short listed based on the percentage of identity. The protein sequences were 
selected as essential genes with the percentage of identity having more than 70%. The observed parameters for 
DEG pBLAST are tabulated (Table 1). 
 
Table 1: observed parameters for DEG pBLAST 
S.No Parameter Value 
1.  Filter ON 
2.  Expect 0.0001 
3.  Matrix BLOSUM 62 
4.  Perform gapped alignment  ON 
5.  Descriptions 100 
6.  Alignments 100 
 
2.3. Identifying the Non-Human Homologous Proteins 
All the protein coding sequences of B. anthracis were also analyzed for sequence similarity with 
human proteome using Human-BLASTP (H-BLAST) database [10] with an E-value cutoff of 10. Non-human 
homologous proteins were identified based on the criterion that the percent of identity should be less than 20%.  
The observed parameters for H-BLAST are tabulated (Table 2). 
 
Table 2: observed parameters for H-BLAST 
S.No Parameter Value 
1.  Database                           RefSeq protein 
2.  Max target sequences      100 
3.  Expect threshold 10 
4.  Word size 3 
5.  Matrix BLOSUM 62 
6.  Gap costs Extension:11 Extension:1 
7.  Compositional adjustments     Conditional compositional 
score matrix 
8.  Filter Low Complexity Region   
9.  Algorithm blastp (protein-protein 
BLAST) 
 
2.4. Predicting Subcellular Localization of Essential and Non-Human Homologous Proteins 
PSORTb v3.0.2 is the most precise bacterial localization prediction tool which accepts the fasta 
formatted protein sequences [11]. By selecting the following parameters: Organism-Bacteria; Gram Stain-
Positive; Output format-Normal, the sequences of obtained essential genes and non-human homologs were 
submitted for their subcellular localization prediction.  
 
2.5. Selecting the putative ‘Best’ Drug Targets 
For consideration of ‘best’ drug targets, the following three different criterias were implemented [13]. 
1. The protein must be a non-human homolog. 
2. The 3D structure availability in PDB and its highest percentage identity with of the same             
B. anthracis species. 
3. The protein must be an essential molecule for the survival of the organism.  
 
The protein sequences which satisfy the criteria of being non-human homologs are subjected to PDB-
BLAST [14] to retrieve the most significant 3D structures. The 3D structures of the proteins were short listed 
based upon the cutoff percentage identity between sequence and the structure to be 60%.  
The observed parameters for PDB-BLAST are tabulated (Table 3). 
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Table 3: observed parameters for PDB-BLAST 
S.No Parameter Value 
1.  Database                           Protein Data Bank PDB 
2.  Max target sequences      100 
3.  Expect threshold 10 
4.  Word size 3 
5.  Matrix BLOSUM 62 
6.  Gap costs Extension:11 Extension:1 
7.  Compositional adjustments     Conditional compositional 
score matrix 
8.  Filter Low Complexity Region   
9.  Algorithm blastp (protein-protein 
BLAST) 
 
3. RESULTS AND ANALYSIS 
 
3.1 Genome, Proteome and Metabolic Profile of B. anthracis 
From the JCVI-CMR database, the retrieved number of protein-coding genes from genome and the 
plasmids pXO1 and PXO2 of B. anthracis (CDC 684) genome are 5579, 206, 117 respectively resulting in total 
of 5902 numbers of proteins. The detailed genome and proteome components information from NCBI and 
UniprotKB respectively are shown in figure 2.   
 
 
Figure 2. Genome and Proteome Components of B. anthracis CDC 684 Strain 
 
All the genes/proteins in JCVI-CMR were annotated into 21 functional metabolic categories. Among 
those gene role categories, 35.8 % of genes were encoded from the category of Hypothetical Proteins and 
Conserved Hypothetical proteins. Other than hypothetical proteins, there are genes categorized as Unknown 
Function comprising of 11.9 %. Hence the remaining 52.3 % of genes are categorized into key metabolisms. 
Among these key metabolisms, the major numbers of genes are involved in the metabolisms of cell envelope, 
cellular processes, regulatory functions and transport and binding proteins. This study signifies that the 
biochemical processes are requiring more than 50 % of the total genome of the bacterium. 
 
3.2. Defining Essential Genes/Proteins in Discovery of Minimal Gene Complement 
The database of essential genes hosts records of essential genes among a wide range of organisms 
including both prokaryotes and eukaryotes. Essential gene products can be represented as good targets for 
antibacterial drugs. The screening of the each gene product of B. anthracis is done by considering the sequence 
identity to be > 70 % against the DEG prokaryotic pBLAST.  From the DEG-BLAST studies, the total number 
of 146 essential genes were predicted. Among them the number of redundant and conserved hypothetical 
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proteins predicted were 4 and 6 respectively. They were removed from the final count resulting in 136 numbers 
of essential genes.  From all the metabolisms, the majority of the essential genes were predicted from protein 
synthesis metabolism which can be suggested that protein anabolism is highly essential for the survival of the 
organism. The further DEG results were summarized in the table 4. Many of predicted essential genes were 
exhibiting poor range of 20-40% sequence similarities with the human proteome. All the details of 136 gene 
products with corresponding metabolic family, gene id, common name, EC number including the subcellular 
localization "and" prediction of the protein were provided in the Supplementary Table 1. 
Essential genes/proteins can also be treated as potential and important drug candidates as well vaccine 
candidates if they are membrane-based proteins or enzymes. As only 136 gene products were predicted as 
essential genes which comprises of only 2.3 % of the total genes, they can also serve as minimal gene 
complement signifying the minimum number of proteins necessitated for the organism’s critical metabolic 
pathways and its survival [12].  
 
Table 4. Summary of DEG (Database of Essential Genes) Screening Analysis 
Essential genes predicted 146 
Redundant + Conserved hypothetical proteins  (4 + 6) 10 
Essential genes as enzymes 73 
Essential genes which are cytoplasmic   118 
Total number of essential genes considered 136 
  
3.3. Non-Human Homologs (NHHs) are the most preferable drug/vaccine candidates 
The same previously retrieved dataset which was used to screen DEG was employed to identify the 
non-human homologs by performing H-BLAST (Human-specific BLAST). The sequence identities of <20% 
between proteomes of B. anthracis and human were considered as reliable drug targets. As the dataset is 
metabolic profile based proteome, some proteins such as toxins, family based transcriptional regulators, 
polysaccharide synthase family proteins, histidine kinases, DNA-binding response regulator proteins, etc which 
were existing in redundant numbers were not included in the JCVI-CMR database. By screening the entire 
proteome of B. anthracis against H-BLAST, a total number of non-human homologs predicted were 145. The 
redundant proteins were removed and further subjected to PDB-BLAST to retrieve the appropriate 3D 
strucutres.  The 3D structures of the protein molecules are necessary for further studies like identification of 
active sites and for protein-ligand docking. The 3D strucutres which have the sequence identity percentage of 
>60% with respect to non-human homolog sequnce were only considered as important for further selection of 
suitable of drug targets. The detailed H-BLAST and PDB-BLAST results were summarized in the Table 5. All 
the details of 145 non-human homologs with corresponding metabolic family, gene locus, common name, EC 
number, protein length, PDB Id and its corresponding percent identity and the subcellular localization prediction 
of the non-human homolog were provided in the Supplementary Table 2. 
 
Table 5. Summary of H-BLAST and PDB-BLAST Screening Analysis 
Non-human homologs predicted 145 
Hypothetical proteins / Uncharacterized proteins 11 
Putative membrane proteins predicted 9 
Putative lipoproteins predicted 5 
Non-human homologs localized in cytoplasm   51 
Non-human homologs localized in cytoplasmic membrane 55 
Non-human homologs localized in cell wall and extracellular 7 
3D structures obtainable for NHHs 69 
Total number of Non-human homologs considered as putative drug targets 
(Essential + Non-human homolog + Availability of better 3D-Structure + Important Functional role) 8 
3D Structures availability with >90% sequence/structural similarity 3 
 
 
3.4. Selection of ‘functional’ drug targets obtained through criteria based database screening 
Total number of protein coding genes that fulfill the criteria of being essential and non-human 
homologs genes with their respective metabolic function are graphically represented in the Figure 3. The total 
numbers of essential genes that are required for the B. anthracis for its minimum survival are 136 genes.  
Among them the majority of the genes (56) are involved in the protein synthesis metabolism. The total numbers 
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of genes that are non-human homologs i.e., absent in humans or don’t play any important role in human 
metabolism were predicted to be 145, of which the genes coding for cell envelope and transport binding proteins  
metabolisms are more in number with a count of 35 and 32 respectively.  
 
 
 
Figure 3. Number of Essential Genes and Non-Human Homologs Hits obtained 
 
 
The screening of 145 NHHs against PDB-BLAST resulted in retrieval of 69 similar three-dimensional 
protein structures and for the remaining 76 numbers of proteins, no significant protein structures were available 
in PDB. On the basis of PDB-BLAST alignments, the sequences having percentage identity of >60% were 
considered to be reliable 3D structures for the prospective drug targets. Out of 145, 69 NHHs were possesing the 
3D structures whereas for the remaining 76 NHHs 3D structures were not available in the PDB. The 
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hypothetical / uncharacterized proteins (11), putative membrane proteins (9), and putative lipoproteins (5) were 
not considered for further selection as the information regarding them were poorly annotated. The cytoplasmic 
membrane (55), cell wall and extracellular proteins (7) can be better drug candidates than cytoplasmic proteins 
(51) as they are readily available to interact with the external molecules on the bacterial surface (Figure. 4).  
 
 
 
 
 
Figure 4. Flow Chart representing the selection of ‘functional’ drug targets 
 
The eight common hits in both DEG and H-BLAST screening (Table 6) were considered to be the  
most putative and ‘functional’ drug targets as they do not resemble to any of the human proteins. It plays an 
essential role for the survival of the organism, and readily available  with similar structural analogue. The 3D 
structure of a protein plays critical role in understanding the cellular processes as well as the mechanism of 
catalysis. These studies provide nessesary information regarding the drug target which could be helpful to the 
structural bioinformatician and researchers working in drug discovery processes. 
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Table 6. List of common protein hits obtained in DEG & H-BLAST Screening 
 
 
4. CONCLUSION 
The free availability of the genome/proteome sequences and user friendly tools of bioinformatics has led to 
an enormous activity in analyzing the biological data resulting in interpretion of the biological information by 
making accurate inferences or predictions. In the current study, the B. anthracis proteome was screened against 
the database of essential genes, human specific-BLAST database and PDB-BLAST database to identify the 
probable essential genes/proteins and non-human homologous proteins. A series of functional selection critiria 
was implemented in retrieving and analyzing the sequences data which resulted in predicting the significant 
putative drug targets. The requirement of novel drug targets are principally necessitated in providing the 
alternative paths to combat the pathobiology of B. anthracis.  
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